AMNV-siAEBP1

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameAMNV-siAEBP1
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionGene silencing
TargetsAdipocyte enhancer-binding protein 1
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYonsei University
China Registration ClassN/A

Develop Information

Active CompaniesYonsei University
Inactive CompaniesN/A
Active IndicationsAtrial Fibrillation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A